التفاصيل البيبلوغرافية
| العنوان: |
Residual Weighted Learning for Estimating Individualized Treatment Rules. |
| المؤلفون: |
Zhou, Xin, Mayer-Hamblett, Nicole, Khan, Umer, Kosorok, Michael R. |
| المصدر: |
Journal of the American Statistical Association; Mar2017, Vol. 112 Issue 517, p169-187, 19p |
| مصطلحات موضوعية: |
CLINICAL trials, TUBERCULOSIS, ANTIRETROVIRAL agents, INDIVIDUALIZED medicine, LINEAR statistical models, CYSTIC fibrosis treatment |
| مستخلص: |
Personalized medicine has received increasing attention among statisticians, computer scientists, and clinical practitioners. A major component of personalized medicine is the estimation of individualized treatment rules (ITRs). Recently, Zhao et al. proposed outcome weighted learning (OWL) to construct ITRs that directly optimize the clinical outcome. Although OWL opens the door to introducing machine learning techniques to optimal treatment regimes, it still has some problems in performance. (1) The estimated ITR of OWL is affected by a simple shift of the outcome. (2) The rule from OWL tries to keep treatment assignments that subjects actually received. (3) There is no variable selection mechanism with OWL. All of them weaken the finite sample performance of OWL. In this article, we propose a general framework, called residual weighted learning (RWL), to alleviate these problems, and hence to improve finite sample performance. Unlike OWL which weights misclassification errors by clinical outcomes, RWL weights these errors by residuals of the outcome from a regression fit on clinical covariates excluding treatment assignment. We use the smoothed ramp loss function in RWL and provide a difference of convex (d.c.) algorithm to solve the corresponding nonconvex optimization problem. By estimating residuals with linear models or generalized linear models, RWL can effectively deal with different types of outcomes, such as continuous, binary, and count outcomes. We also propose variable selection methods for linear and nonlinear rules, respectively, to further improve the performance. We show that the resulting estimator of the treatment rule is consistent. We further obtain a rate of convergence for the difference between the expected outcome using the estimated ITR and that of the optimal treatment rule. The performance of the proposed RWL methods is illustrated in simulation studies and in an analysis of cystic fibrosis clinical trial data. Supplementary materials for this article are available online. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of the American Statistical Association is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
